Purchase Order 75N91020P00834
Award Date 9/16/20
Potential Completion Date 9/15/22
Potential Value $119K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Aurora, CO 80045, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute (NCI) awarded a $293,970 firm fixed-price purchase order to the University Health Network (UHN), doing business as the Toronto General And Western Hospital Foundation, to retrieve existing clinical and treatment data for at least 500 pediatric cancer patients treated with photon therapy since 2007. This data will be used to evaluate photon therapy as a cancer treatment for pediatric patients as part of the U.S. Pediatric Photon Therapy Comparison Cohort Study. The...
- The U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $150,577.00 firm fixed-price purchase order to Children's Hospital Los Angeles to retrieve existing clinical and treatment data for a comparison cohort of at least 500 pediatric cancer patients treated with photon therapy since 2007. The data will be used to evaluate the U.S. Pediatric Photon Therapy Comparison Cohort Study. There was no set-aside designation for this procurement....
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Cancer Institute (NCI) to the University of Florida Division of Sponsored Research. The contract has a potential value of $159,826.00 and a period of performance ending on March 15, 2023. The contract is part of the US Pediatric Proton/Photon Therapy Cohort Study, which aims to obtain data on pediatric cancer patients treated with proton or photon therapy. The contract was...
- The National Cancer Institute (NCI) awarded a $249,997 firm fixed-price purchase order to The Washington University's Office of Sponsored Research Services on November 1, 2024, for medical record abstraction services supporting the Pediatric Proton and Photon Therapy Comparison Cohort study. Under this 14-month contract through June 30, 2026, Washington University will retrieve and abstract de-identified clinical and treatment data from medical records of pediatric cancer patients who received...
- The National Cancer Institute (NCI) has awarded a $248,767 firm fixed-price purchase order contract to Proton Doctors Professional Corporation for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. This contract is not set-aside. The goal is to obtain de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated with...
- This federal contract award is for a Definitive Contract with a Ceiling Value of $570,344,932.37, awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The contract is for "BIOMEDICAL (BASIC)" services and has an Ultimate Completion Date of December 31, 2011. The University of Colorado-Denver is a major public research university that...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the University Health Network (UHN), doing business as the Toronto General And Western Hospital Foundation, to procure existing clinical and treatment data on at least 500 pediatric cancer patients treated with photon therapy since 2007. The contract, valued at $97,021.21, is part of the NCI's Cancer Genome Atlas (TCGA) program and will support the U.S. Pediatric Photon Therapy Comparison...
- The National Cancer Institute awarded a $250,000 firm fixed-price purchase order to Baylor College of Medicine on June 27, 2023, to support the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing the risks and benefits of proton versus photon radiation therapy in pediatric cancer patients. Under this non-set-aside contract, Baylor College of Medicine serves as the prime contractor with performance in Houston, Texas, and is scheduled to complete work by June...
- This firm fixed-price purchase order was awarded by the National Cancer Institute, part of the Department of Health and Human Services, to the University of Utah Office of Sponsored Projects Division. The goal of this $249,996.00 contract is to obtain data on a group of proton-treated pediatric cancer patients and a photon-treated comparison group, to support the U.S. Pediatric Proton/Photon Therapy Cohort Study. No set-aside designation was used. The University of Utah is a top-tier research...
- This is a $120,854 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the University of Colorado-Denver. The contract is for the University of Colorado-Denver to provide laboratory testing and autoimmune biomarker assays on serum samples from participants in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial and the Alpha-Tocopherol, Beta-Carotene (ATBC)...